← Back to Patent Explorer
US4783446A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for the treatment of AIDS virus and other retroviruses

Assignee: Neushul Mariculture Inc
•
Filing: 1987-02-25
•
Granted: 1988-11-08
•
Expires: 2007-02-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The subject invention concerns the use of a carrageenan and other sulfated polysaccharides to treat AIDS and other infections caused by retroviruses. The invention also concerns a method for stimulating T-cell activity in humans and animals with carrageenans and other sulfated polysaccharides.

Inventors

  • 👤 Michael Neushul

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 22:04
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/715; A61P; A61P31/00; A61P31/12; A61P37/00; A61P37/02; A61P37/04

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 32 words
A method of treating retrovirus infections in humans and animals which comprises treating a retrovirus-infected human or animal host with an anti-retroviral effective amount of a carrageen, or a mixture of carrageenans.
Claim 2
Independent Claim 32 words
A method of treating retrovirus infections in humans and animals which comprises treating a retrovirus-infected human or animal host with an anti-retroviral effective amount of a carrageen, or a mixture of carrageenans.
Claim 3
Dependent Claim 12 words
A method, in accordance with claim 1, wherein said retrovirus is HTLV-III.
Claim 4
Dependent Claim 15 words
A method, in accordance with claim 1, wherein said carrageenan is adapted for systemic application.
Claim 5
Dependent Claim 16 words
A method, according to claim 1, wherein said carrageenan is lambda, or kappa, or iota carrageenan.
Claim 6
Dependent Claim 14 words
A method, according to claim 1, wherein said carrageenan is in the salt form.
Claim 7
Independent Claim 28 words
A method of treating retrovirus infections in humans and animals which comprises treating a retrovirus-infected human or animal host with an anti-retroviral effective amount of a sulfated polysaccharide.
Claim 8
Independent Claim 28 words
A method of treating retrovirus infections in humans and animals which comprises treating a retrovirus-infected human or animal host with an anti-retroviral effective amount of a sulfated polysaccharide.
Claim 9
Independent Claim 36 words
A method for stimulating T-cell activity in humans and animals comprising administering to a human or an animal, in need of T-cell stimulation, a T-cell stimulating effecive amount of a carrageenan, or a mixture of carrageenans.
Claim 10
Independent Claim 36 words
A method for stimulating T-cell activity in humans and animals comprising administering to a human or an animal, in need of T-cell stimulation, a T-cell stimulating effecive amount of a carrageenan, or a mixture of carrageenans.
Claim 11
Dependent Claim 15 words
A method, in accordance with claim 7, wherein said carrageenan is adapted for systemic application.
Claim 12
Dependent Claim 16 words
A method, according to claim 7, wherein said carrageenan is lambda, or kappa, or iota carrageenan.
Claim 13
Dependent Claim 14 words
A method, according to claim 7, wherein said carrageenan is in the salt form.

References Cited (Backward Citations)

US4162309A Cited
US4162308A Cited
US4522814A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-11-08 1992-05-09 1992-11-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-11-08 1996-05-09 1996-11-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-11-08 2000-05-09 2000-11-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag